Md_acevedo_mejor__resolucion.jpg_thumb90

MONICA ANDREA ACEVEDO BLANCO

Titular Professor

P. UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

Líneas de Investigación


CARDIOVASCULAR RISK FACTORS: TADITIONAL AND NEW RISK MARKERS. HYPERTENSION; DYSLIPIDEMIA; CORONARY HEART DISEASE DIAGNOSIS AND TREATMENT. CARDIOVASCULAR DISEASE IN WOMEN. nON INVASIVE MARKERS FOR CARDIOVASCULAR DISEASE

Educación

  •  Medical Doctor, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 1990

Experiencia Académica

  •   HEAD PREVENTIVE CARDIOLOGY AND CARDIAC REHAB Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    MEDICINE

    SANTIAGO, Chile

    1997 - A la fecha

  •   Professor of Medicine Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    MEDICINE

    SANTIAGO, Chile

    1997 - A la fecha

  •   Head Section Preventive Cardiology and Cardiac Rehabilitation Full Time

    RED DE SALUD UCCHRISTUS

    MEDICINE

    SANTIAGO, Chile

    2002 - A la fecha

  •   Head, Women and Cardiovascular Disease program, Section Preventive Cardiology Full Time

    RED DE SALUD UCCHRISTUS

    MEDICINE

    SANTIAGO, Chile

    2006 - A la fecha

  •   Staff Cardiologist, Intermediate Coronary Care Unit, Hospital UC-Christus Full Time

    RED DE SALUD UCCHRISTUS

    MEDICINE

    SANTIAGO, Chile

    2017 - A la fecha

Experiencia Profesional

  •   Residency in Internal Medicine Full Time

    Catholic University of Chile

    Chile

    1990 - 1993

  •   Fellowship in Cardiology Full Time

    Catholic University of Chile

    Chile

    1993 - 1995

  •   Scholarship in Cardiology Full Time

    The Cleveland Clinic Foundation

    Estados Unidos

    1999 - 2001

Formación de Capital Humano


1997-1997 : Semiology Tutor for the Integrated Course of Medical-Surgical Clinics MEC 231, third-year Medicine students. 60 teaching hours, Hospital Clínico, Faculty of Medicine UC.
1997-1999 : Internal Medicine tutor tutor during rotation in the Coronary Unit. 500 annual teaching hours, Hospital Clínico, Faculty of Medicine UC.
1997 : Tutor tutor with Internal Medicine scholarships during rotation in the Coronary Unit. 500 annual teaching hours, Hospital Clínico, Faculty of Medicine UC.
1997-1999 : Tutor teacher of Cardiology scholarship holders during rotation in. Coronary Unit. 800 annual teaching hours, Hospital Clínico, Faculty of Medicine UC.
1997-1997 : Tutor in Cardiology Seminars for third and fourth year Medicine students. 6 teaching hours, Hospital Clínico, Faculty of Medicine UC.
1998-1998 : Semiology Tutor for the Integrated Course of Medical-Surgical Clinics MEC 231, third-year Medicine students. 60 teaching hours, Hospital Clínico, Faculty of Medicine UC.
1998-2002 : Semiology Tutor for the Integrated Course of Medical-Surgical Clinics MEC 231, third-year Medicine students. 60 teaching hours, Hospital Clínico, Faculty of Medicine UC.
2002-2002 : Talk on Cardiovascular Risk Factors for students, Medicine interns, Medicine fellows and staff, Hospital Clínico, Faculty of Medicine UC.
2002-2002 : Talk: Cardiovascular Risk Factors, delivered for the Internal Medicine clinical meeting, Hospital Clínico, UC School of Medicine.
2002-2002 : Semiology Tutor for the Integrated Course of Medical-Surgical Clinics MEC 231, third-year Medicine students. 60 teaching hours, Hospital Clínico, Faculty of Medicine UC.
2002-2002 : Core Curriculum 2002: Primary and Secondary Prevention for Cardiology fellows, Hospital Clínico, UC School of Medicine.
2002-2002 : Tutor in Cardiology Seminars for third and fourth year Medicine students. 9 teaching hours, Hospital Clínico, Faculty of Medicine UC.
2002-2002 : Talk on the "Heart Protection Study (HPS)" study, delivered for the Internal Medicine clinical meeting, Hospital Clínico, UC School of Medicine.
2003-The date : Semiology Tutor for the Integrated Course of Medical-Surgical Clinics MEC 231, third-year Medicine students. 60 teaching hours, Hospital Clínico, Faculty of Medicine UC.
2003-The date : Tutor in Cardiology Seminars for third year Medicine students. 9 teaching hours, Hospital Clínico, Faculty of Medicine UC.
2003-The date : Tutor in Cardiology Seminars for third year Medicine students. 9 teaching hours, Hospital Clínico, Faculty of Medicine UC.
2005-2006 : Internal Medicine Diploma. 1 Hour, Clinical Hospital, UC School of Medicine.
2005-The date : MEC 246 G/H, Integrated Course of surgical medical clinics 4th year. 2nd semester, 1 class and 4 clinical sessions, 12 students, Clinical Hospital, UC School of Medicine.
2005-2005 : Post Graduate Course "Diagnostic Techniques in Medicine", with class, 4 Classes, 4 Hrs, Clinical Hospital, UC School of Medicine.
2005-2006 : Head of the "Cardiovascular Prevention Improvement Stay in the Department of Cardiovascular Enf.". Taught by the Postgraduate Department, Hospital Clínico, Faculty of Medicine UC.
2006-2006 : Integrated Clinical Course II MED302A as a teacher in charge of third year students, Oct/Nov period, Hospital Clínico, Faculty of Medicine UC.
2006-The date : MEC 251, Integrated Course of surgical medical clinics 5th year. 2nd semester, 2 classes and 6 clinical sessions, 12 students, Clinical Hospital, UC School of Medicine.
2007-2007 : External evaluator Master's Program in Nutrition, Dr. Rodrigo Soto, Hospital Clínico, Faculty of Medicine UC.
2007-2007 : Integrated Clinical Course II MED302A as a teacher in charge of third year students, August 2007, Heart Examination Workshop, Hospital Clínico, Faculty of Medicine UC.
2007-2007 : Tutor, Integrated Clinical Course II MED302A, in charge of First Clinical Rotation, Aug 28 to Oct 12, Hospital Clínico, Faculty of Medicine UC.
2007-2007 : Supervisor, Integrated Course of Clinic II MED302A, in the ECOE exam, November 2007, Hospital Clínico, Faculty of Medicine UC.
2008-2008 :Integrated Clinical Course III MED402A, Cardiovascular Prevention Class, Hospital Clínico, Faculty of Medicine UC.
2008-2008 : Chapter MED401A Outpatient Teaching, 2 weeks 6 students, Hospital Clínico, Faculty of Medicine UC.
2008-2008 : Supervisor, Integrated Course of Clinic II MED302A, in the ECOE exam, Hospital Clínico, Faculty of Medicine UC.
2008-2008 : Integrated Clinical Course III MED402A as a teacher in charge of fourth year students, September 2008, Clinical Cases I, II, III, IV, group I, Hospital Clínico, Faculty of Medicine UC.
2008-2008 : MED501A Seminars Integrated Course Medical Clinics, Fifth Year Cardiology, Hospital Clínico, Faculty of Medicine UC.
2008-2008 : Core Curriculum Cardiology Scholarship, Hospital Clínico, Faculty of Medicine UC
2009-2009 : Integrated Clinical Course III MED402A as a teacher in charge of fourth year students, September 2009, Clinical Cases I, II, III, IV, group I, Hospital Clínico, Faculty of Medicine UC.
2009-2009 : Core Curriculum Cardiology Scholarship, Clinical Hospital, UC School of Medicine.
2010-2010 : Integrated Clinical Course III MED402A as a teacher in charge of fourth year students, September 2010, Clinical Cases I, II, III, IV, group I, Hospital Clínico, Faculty of Medicine UC.
2010-2012 : MED501A Seminars Integrated Course Medical Clinics, Fifth Year Cardiology, Hospital Clínico, Faculty of Medicine UC.
2010-2010 : Core Curriculum Cardiology Scholarship, Clinical Hospital, UC School of Medicine.
2011-2011 : Integrated Clinical Course III MED402A as a teacher in charge of fourth year students, September 2010, Clinical Cases, Hospital Clínico, Faculty of Medicine UC.
2011-2011 : Seminars Course Cardiovascular Physiopathology, 3rd Year, Hospital Clínico, Faculty of Medicine UC.
2011-2012 : Dr Kanacri Cardiology Scholarship Thesis Evaluator, Faculty of Medicine, PUC
2011-2011 : Core Curriculum Cardiology Scholarship, Clinical Hospital, UC School of Medicine.
2011-2012 : Core Curriculum Cardiology Scholarship, Clinical Hospital, UC School of Medicine.
2013-2013 : Class: Most relevant health problems in the climacteric period: cardiovascular disorders. Course ENO3190, Faculty of Medicine, PUC
2013-2013 : Core Curriculum Scholarship Cardiology, Core Curriculum Scholarship Cardiology.
2013-2013 : Seminar V year, Atherosclerotic disease. , Clinical Hospital, UC School of Medicine.
2013 : Diabetology Seminar. CV screening in the diabetic patient Mr Salman. , Core Curriculum Scholarship Cardiology
2013-2013 : Clase Curso Optativo ENO3190 Cuidados de Enfermería para un Climaterio Saludable. , Escuela Enfermería, PUC
2014-2014 : Course on General Physiopathology and Systems of Kinesiology and Speech Therapy (MEK 202-A and MEF 202-A) Class Atherosclerosis and cholesterol metabolism, Faculty of Medicine, PUC
2014-2014 : Morphological and functional pathology. (MED 303A) Class Atherosclerosis and thrombosis 3, Atherosclerosis and thrombosis 4. Atherosclerosis and thrombosis 5. , Faculty of Medicine, PUC
2014-2014 : Nutrition Pathophysiology Program MEN 202-A. Atherosclerosis and Dyslipidemia Classes. , Faculty of Medicine, PUC
2014-2014 : Cardiology Seminar Program for the Fifth Year of Medicine (Integrated Course of Medical Clinics (MED 501A) 3 Clinical Cases. , School of Medicine, PUC
2014-2014 : SSMSO Blood Pressure Measurement Certification Course Class: "Current Situation of Cardiovascular Risk Factors", School of Nursing, PUC
2014-2014 : Internal Evaluator Thesis Study of Dysfunction Markers in Metabolic Syndrome: Evaluation of the RhoA/ROCK pathway as a possible signaling axis. Student Alberto Leguina Ruzzi. , Faculty of Medicine, PUC
2015 Apr: Round Table Course on Cardiovascular Prevention 2015. April 24-25, 2015. Santiago-Chile.
2015 Aug: Talk: Pathophysiology of atherosclerotic Disease. Role of dyslipidemia. Annual Course Chilean Society of Cardiology and Cardiovascular Surgery. August 6 and 7, 2015. Santiago-Chile.
2015 Aug: Talk: Medical therapy in dyslipidemias: therapeutic objective or cardiovascular risk management. Annual Cardiology Course, DIPRECA Hospital. August 14 and 15, 2015, Santiago-Chile.
2015 Aug: Talk: Latest Cardio-Vascular Prevention Guidelines. 7th Cuyano Symposium on Cardiovascular Disease in Women. August 20-21, 2015, Mendoza, Argentina.
2015 Aug: Expert Panelist: CONAREC Activities. Presentation of Clinical Cases 1, 2, and 3. 7th Cuyano Symposium on Cardiovascular Disease in Women. August 20-21, 2015, Mendoza, Argentina.
2015 Aug: Talk: Use of Estrogens and CV Risk? Actual state. 7th Cuyano Symposium on Cardiovascular Disease in Women. August 20-21, 2015, Mendoza, Argentina.
2015 Au : Talk: Smoking and Cardiovascular Disease in women. PUC Smoking prevention and treatment course. August 24, 2015, Santiago-Chile.
2015 Dec: Discussion meeting and preparation of the Expert Document on atherogenic dyslipidemia in Latin America. XXV Ibero-American Congress of Cardiology and Cardiovascular Surgery, December 4 - 7, 2015, Santiago-Chile.
2015 Dec: Symposium of the South American Society of Cardiology "Council on Cardiovascular Disease in Women" SIAC/Sochicar. Chair: Dr. Mauricio Fernández, Mónica Acevedo and Roberto Díaz del Castillo. XXV Iberoamerican Congress of Cardiology and Cardiovascular Surgery, 4-7 Dec. 2015, Santiago-Chile
2015 Jul: Invited Professor to give 3 classes in Master of Clinical Physiology of Exercise, Finis Terrae University July 2015.
2015 Jun: Talk: Cardiovascular Rehabilitation. Annual Postgraduate Course, Decision Making in Cardiology and Cardiovascular Surgery. Santiago- Chile 18-20 June 2015.
2015 Jun: Round Table: Prevention Module R. Corbalan, M. Acevedo. Annual Postgraduate Course, Decision Making in Cardiology and Surgery Cardiovascular. Santiago-Chile 18-20 June 2015
2015 Jun: Talk: Established and Emerging lipid lowering Drugs. Attendance 20th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy (ISCP). Buenos Aires-Argentina 25-26 June 2015.
2015 Mar: Talk: Advocating for improvements in cardiovascular disease prevention: crossing the bridge between the academic and the real world. 64th American College of Cardiology, ACC 15. San Diego, USA. 14-16 March 2015.
2016 Apr: Talk: Evaluation of cardiovascular risk in diabetic patients. Cardiovascular Prevention Course 2016. April 22-23, 2016, Santiago- Chile.
2016 Dec: Conference: Evaluation of cardiovascular risk in asymptomatic individuals. LIII Chilean Congress of Cardiology and Cardiovascular Surgery. 30 Nov. - 3 Dec. 2016, Puerto Varas-Chile.
2016 Dec: Conference: Fasting cholesterol remnants are associated with systemic inflammation but would not be predictors of mortality in patients in Primary Prevention. LIII Chilean Congress of Cardiology and Cardiovascular Surgery. 30 Nov. - 3 Dec. 2016, Puerto Varas-Chile.
2016 Dec: Conference: American Risk Score, AHA/ACC. Does it make sense to apply it to our patients? LIII Chilean Congress of Cardiology and Cardiovascular Surgery. 30 Nov. - 3 Dec. 2016, Puerto Varas-Chile.
2016 Dec: PLENARY: Treatment of functional mitral HF Dr Robert Bonow, USA. Presented by Dr Monica Acevedo. LIII Chilean Congress of Cardiology and Cardiovascular Surgery. 30 Nov. - 3 Dec. 2016, Puerto Varas-Chile.
2016 Jun: Continuing Education: World Congress of Cardiology and Cardiovascular Health (WCC 2016). 4-7 June 2016, Mexico.
2016 Jun: Lecture: Diagnosis and treatment of ischemic heart disease. World Congress of Cardiology and Cardiovascular Health (WCC 2016). 4-7 June 2016, Mexico.
2016 Jun: Conference: What are the challenges in treating women with Ischemic heart disease in Latin America? World Congress of Cardiology and Cardiovascular Health (WCC 2016). 4-7 June 2016, Mexico.
2016 Jun: Conference: What's new in treating Arterial Hypertension. Update course in managing cardiovascular risk factors: From theory to clinical practice. June 17, 2016, Santiago-Chile.
2016 May: that Round: Coronary Disease in Women "Rehabilitation and exercise in Heart Failure" Panelist. XXXIV National Congress of Cardiology. May 22-24, 2016 Cordoba-Argentina.
2016 May: Conference: Treatment of coronary heart disease in women:
Are there differences between percutaneous and surgical revascularization, according to the evidence? XXXIV National Congress of Cardiology. May 22-24, 2016 Cordoba-Argentina.
2016 May: Round Table: Dyslipidemias: What's new after the guidelines? Triglycerides: guilty, innocent, or insignificant? XXXIV National Congress of Cardiology. 22-24 May 2016 Cordoba- Argentina.
2017 Jun: Round Table: Refractory arterial hypertension. XIII Annual Postgraduate Course. Decision Making in Cardiology and Cardiovascular Surgery. June 15-16, 2017. Santiago-Chile
2018: Talk: Intolerance to statins, Myth or reality? Dyslipidemia Course. April 13 and 14, 2018, Viña del Mar.
2018: Talk: Hypertension and CV Risk. ACC Highlight Course 2018. April 13 and 14, 2018. Santiago-Chile.
2018: Talk: The concept of "Residual Inflammatory Risk": Reducing inflammation to reduce CV risk? Course 2018 Cardiovascular Prevention. 27-28 April 2018, Santiago-Chile
2018: Talk: Ischemic heart disease. The diagnostic challenge. XXXVI National Congress of Cardiology. May 31 - June 2, 2018, Mendoza- Argentina
2018: Talk: ACO, HRT, and Cardiovascular Risk - Vision of the cardiologist. XXXVI National Congress of Cardiology. May 31 - June 2, 2018, Mendoza Argentina
2018: Talk: Awareness campaign on the impact of cardiovascular disease on women: The experience in Chile. I International Symposium on Cardiovascular Disease in Women. July 13-14, 2018. Maceio, Brazil.
2018: Talk Cardiovascular Disease in Women and Men. The Estrogenic Difference. Postgraduate course Schemes of hormone replacement therapy in the different types of ageing. October 4, 2018, Las Condes, Chile
2018: Talk: What do the new lipid-lowering treatments contribute to cardiovascular prevention? LV Chilean Congress of Cardiology and Cardiovascular Surgery. 28, 29, 30 Nov to 01 Dec 2018. Concepcion- Chile
2018: Talk: Cardiovascular risk assessment in people with diabetes. LV Chilean Congress of Cardiology and Cardiovascular Surgery. 28, 29, 30 Nov to 01 Dec 2018. Concepcion-Chile
2019: Talk: How Does Ethnicity Impact Cardiometabolic Risk? ACC 2019, Annual Scientific Sessions & Expo 16-18 March 2019. New Orleans, USA
2019: Continuing Education: XXVII Inter-American Congress of Cardiology 2019, May 15-18, 2019, Punta Cana, Dominican Republic.
2019: Talk: Women and Coronary Disease. XXVII Congress Inter-American Cardiology 2019, May 15-18, 2019, Punta Cana, Dominican Republic.
2019: Talk: Adverse effects of statins. A fair point. XXVII Inter-American Congress of Cardiology 2019, May 15-18, 2019, Punta Cana, Dominican Republic.
2019: Talk: Use of the polypill in clinical practice. In which patients? XXVII Inter-American Congress of Cardiology 2019, May 15-18, 2019, Punta Cana, Dominican Republic.
2019: Talk: Diabetic Cardiomyopathy. Are we underdiagnosing? Cardiovascular evaluation of the DM patient. IV University Conference on Technology and Innovation in Diabetes May 9-11, 2019. Antofagasta-Chile.
2019: Talk: Dyslipidemia in Women. Dyslipidemia Course. April 5 and 6, 2019. Viña del Mar-Chile
2019: Talk: Cardiovascular risk factors in the peri and post-menopause. Diploma in Gynecological Endocrinology. June 5, 2019, UC Extension Center- Santiago, Chile
2019: Talk: AHA/ACC Guidelines for managing Dyslipidemia: What do we. Annual Course of Cardiology Hospital Dipreca 2019, August 23 and 24, 201. Santiago-Chile.
2019: Talk: Stress test, echo, scintigram, or coronary angio-CT. International Course on Controversies in Diabetes. of the Chilean Society of Endocrinology and Diabetes. August 2019. Santiago, Chile
2020: Talk: Angiotensin-Converting Enzyme Inhibitors and SARS-CoV-2 in an online conference cardiovascular commitment on covid-July 19, 2020, Santiago-Chile.
2020: Talk: Dyslipidemia in women. XIX National Congress of Cardiology of the National Association of Cardiologists of Mexico (ANCAM) October 29 to 31, 2020, digital format, with transmission from Guadalajara,?al. Mexico
2020: Talk: Similarities and differences between the AHA 2018 and European 2019 guidelines on dyslipidemia. LVI Chilean Congress of Cardiology and Cardiovascular S, surgery. December 2020, Santiago-Chile.
2020: Talk: Diabetic cardiomyopathy: current situation of an old enemy. LVI Chilean Congress of Cardiology and Cardiovascular Surgery. December 02-05, 2020, Santiago-Chile.
2020 : Talk: Cardiovascular Rehabilitation Program. Cardiology & exercise program 2020 – sports medicine diploma. September 26, 2020, Santiago-Chile.
2020: Talk: Dyslipidemia in women. XIX National Congress of Cardiology of the National Association of Cardiologists of Mexico (ANCAM) October 29 to 31, 2020, digital format, with transmission from Guadalajara, Jal. Mexico.
2020: Talk: Diabetic Cardiomyopathy: Current situation of an old enemy. LVI° Chilean Congress of Cardiology and Cardiovascular Surgery. LVI° Chilean Congress of Cardiology and Cardiovascular Surgery. virtual from December 02 to 05, 2020
202: Talk: Optimal medical treatment in patients with moderate to severe ischemia. C Cardiovascular prevention in times of pandemic. 15-17 April 2021
2021: SYMPOSIUM Optimizing medical treatment in Atherosclerotic Disease "Compass Study" Speaker: Dra. Mónica Acevedo. Cardiovascular Prevention Course in pandemic time. 15-17 April 2021
2021: Talk: CV risk in patients with DM2. How much impact are we having on reducing it? Guides on how to estimate CV risk. Type 2 Diabetes Event and CV Risk-MEXICO. April 21, 2021, Virtual mode.
2021: Talk: Dimensioning CV risk: new perspectives for an old problem. Symposium: Controlling cardiovascular risk from synergies. April 22, 2021. Virtual mode.
2021: The objectives and strategies of how we treat the usual hypertensive patient. VI Chilean Congress of Hypertension online. June 3, 2021
2021: Talk: Ischemic Heart Disease in Women: How much more do we know? Virtual Congress of the Interamerican Society of Cardiology. June 11, 2021.
2021: Talk: The National Survey of Cardiovascular Risk Factors in Women (ENAFARC)" Virtual Modality.
2021: Talk: THM and Cardiovascular Prevention. Women's Health Days. July 16, 2021. Virtual Modality
2021: Talk: Management of hypertension in the elderly. August 9, 2021. Geriatrics Workshop, Virtual Modality.
2021: Talk: Can we prevent Heart Failure? Transversal Course Heart Failure: from Prevention to Failure 2021: Webinar The heart, protagonist of anticoagulation, August 17, 2021. Sochicar.
2021: Talk: Reducing the burden of cardiovascular disease in women by 2030: Recommendations of the Lancet Commission. 2nd. Inter-American Congress of Cardiovascular Prevention and the 3rd. Virtual Regional Meeting of Cardiology ANCAM 2021, from November 19 to 20, 2021, hybrid modality, in Ciudad Paz, BC, México.
2021: Talk: What is the most effective way to prevent HF? XXIX South American Congress of Cardiology and LVII Chilean Congress of Cardiology and Cardiovascular Surgery. 27-30 Nov 2021, Santiago- Chile.
2021: Talk: Optimal treatment of the patient with Type 2 Diabetes. XXIX South American Congress of Cardiology and LVII Chilean Congress of Cardiology and Cardiovascular Surgery. 27-30 Nov 2021, Santiago- Chile.
2021: "Management of hypertension in the elderly" class in the Cardiogeriatrics Workshop: What should we do differently in the elderly? Held between July 19 and September 6, 2021. Santiago- Chile.
2022: Talk: Can Heart Failure be prevented in Diabetic patients? Online Course on Cardiovascular Prevention 2022. April 21-23, 2022. Online Course
2022: Talk: Cardiovascular risk in the transgender subject. Online Course on Cardiovascular Prevention 2022. April 21-23, 2022. Online Course
2022: Talk: Updated management of HF with preserved EF. 53 Meeting Annuls the Chilean chapter of the American College of Physicians "Internal Medicine in Times of COVID-19. May 24-28, 2022, Santiago-Chile.
2022: Talk: Diabetes Mellitus and Cardiovascular Disease: state of the art. XXI June 2022. June 9-10, 2022. Concepcion-Chile.
2022: Talk: Traditional Risk Factors: Physical inactivity, Sedentary lifestyle. XXIX Interamerican Congress of Cardiology. 08-11 June 2022 Miami-USA
2022: Discussion: Symposium Current Challenges in Cardiovascular Prevention. XXIX Interamerican Congress of Cardiology. June 08-11, 2022 Miami-USA
2022: Talk: Hormone replacement therapy and contraceptives in hypertensive women: current evidence. XXIX Interamerican Congress of Cardiology. June 08-11, 2022 Miami-USA
2022: Talk: XV International Congress of Cardiology - CARDIOLILI 2022, Virtual Cali-Colombia which took place from October 26 to November 5, 2022,
2022: Magisterial Lecture: Cardiovascular health of women: the change towards gender equality. An objective for 2030. XX National Congress of Cardiology, with the theme: "Multidisciplinary Integral Cardiology", from November 9 to 12, 2022, Veracruz-Mexico
2023: Phonoaudiology Physiopathology Diploma Class (MEF 201A), January 2023, Faculty of Medicine, PUC
2023: Continuing Education: ACC.23 Annual Scientific Session & Expo Together With World Congress of Cardiology March 4 - 6, 2023 | New Orleans, LA-USA
2023: Talk: Dyslipidemia as a cardiovascular risk factor in women. Comprehensive management course of cardiovascular risk in women. March 18, 2023. Santiago-Chile
2023: Plenary Moderator: III Heart Failure in women. VII International Cardiology Course, March 23-25, 2023 Santiago-Chile.
2023: Talk: Women and Cardiovascular Health. Women's Month Activity SEREMI de Salud Aysén. March 2023
2023: Talk: Dyslipidemia as a cardiovascular risk factor in women Comprehensive Cardiovascular Risk Management Course. March 2023, Santiago-Chile.
2023: Continuing Education: XVII Curso Anual de Prevención Cardiovascular 2023, April 21-22, 2023 Santiago-Chile
2023: Continuing Education: XVII Cardiovascular Prevention Course. Cardiovascular Prevention An approach from the Individual Factors and their Environment. April 21 and 22, 2023. Santiago-Chile
2023: Pathophysiology of Atherosclerosis and Dyslipidemia class for nutrition students. May 2023 PUC School of Medicine
2023: Cardiology Seminar No. 1 "Structure, contraction and Cardiac Cycle - Course MED310B, May 2023, Faculty of Medicine, PUC
2023: Cardiology Seminar No. 2 “Cardiac Function and Cardiac Overload - Course MED310B, May 2023, Faculty of Medicine, PUC
2023: Cardiology Seminar N°3 “Heart Failure - Course MED310B, May 2023, Faculty of Medicine, PUC
2023: Cardiology Seminar N°4 “Myocardial ischemia - Course MED310B, May 2023, Faculty of Medicine, PUC
2023: Talk: Gender Differences in the Impact of DM2 on ASCVD and HF. V Version of the University Conference on Technology and Innovation in Diabetes. May 26-27, 2023. Antofagasta-Chile
2023: Talks: National and International Congress of Cardiology 2023. May 31 to June 03, 2023, Tegucigalpa-Honduras
2023: Talk: Women in Cardiology: empowering women leaders and changing the status quo for women's health. June 7-9, 2023. 30th Inter-American Congress of Cardiology. City of Panama
2023: Talk: The Lancet and Women and Cardiovascular Disease - updates on our goals for reducing the global burden in 2023. June 7-9, 2023. 30th Inter-American Congress of Cardiology. City of Panama


Premios y Distinciones

  •   Mc Clure Foundation Award

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile, 1994

    Yhe best clinical paper presented at the XXXI National Congress of the Chilean Society of Cardiology and Cardiovascular Surgery in 1994: “Electrophysiological Variants of Incessant Tachycardia”.

  •   Razavi Clinical Scholar Award

    CLEVELAND CLINIC FOUNDATION

    Estados Unidos, 1999

    The International Center of the Cleveland Clinic Foundation, Ohio, USA for a clinical scholarship for 2 years to an international physician. July 1999

  •   Fundación Mc Clure

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile, 1997

    The best clinical paper presented at the XXXIV National Congress of the Chilean Society of Cardiology and Cardiovascular Surgery Congreso Chileno de Cardiología y Cirugía Cardiovascular. "Correlación entre Factor de Crecimiento Insulínico tipo 1, Citoquinas proinflamatorias y Activación Neurohumoral en pacientes con insuficiencia cardíaca crónica" de los autores: M. Acevedo, R. Corbalán, J. Jalil, C. Campusano, F. Arteaga,P. Castro y C. Nazzal.

  •   Beca Presidente de la República

    MINISTERIO DE EDUCACION

    Chile, 2000

    2000-2001-2002, durante la formación de postgrado en Cardiología Preventiva en USA.

  •   Peskind Award

    CLEVELAND CLINIC FOUNDATION

    Chile, 2001

    The best paper presented by a fellow in the Department of Internal Medicine at the Cleveland Clinic Foundation

  •   Fundación Mac Clure

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile, 2003

    XL National Congress of the Chilean Society of Cardiology and Cardiovascular Surgery "Proteína C Reactiva y Trombomodulina Soluble: "Predictores Bioquímicos de Mantención de Ritmo Sinusal a 1 Año en pacientes con Fibrilación Auricular".

  •   Fundación de Cardiología de Chile

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile, 2006

    The best clinical paper presented at theXLII National Congress of the Chilean Society of Cardiology and Cardiovascular Surgery, Proteína c-reactiva y su relación con medidas antropométricas y factores de riesgo cardiovascular en niños sanos de la región metropolitana.

  •   Premio Fundacion de Cardiologia de chile

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile

    The best clinical paper presented at the XL National Congress of the Chilean Society of Cardiology and Cardiovascular Surgery. Síndrome metabólico y ateroesclerosis temprana en niños. S. Barja, M. Acevedo, P. Arnaiz, X. Berríos, B. Guzmán, J. Carvajal, B. Cassis, L. Villarroel.

  •   Premio Prevencion Cardiovascular

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile, 2007

    The best clinical paper presented at the XLIV National Congress of the Chilean Society of Cardiology and Cardiovascular Surgery. Niveles de Adiponectina y su relación con parametros antropometricos y factores de riesgo Cardiovascular en niños. P. Arnaiz, M. Acevedo, S. Barja, M. Aglony, B. Guzmán, B. Cassis, J. Carvajal, M. Moreno, X. Berríos.

  •   Premio Fundacion de Cardiologia

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile, 2008

    The best clinical paper presented at the XLV National Congress of the Chilean Society of Cardiology and Cardiovascular Surgery. Modificacion del grosor intima-media carotideo segun factores de riesgos clasicos y sindrome metabolico con y sin inflamacion.

  •   Premio Excelencia Clínica Junior

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Chile, 2009

    Premio Excelencia Clínica Junior. Facultad de Medicina UC.

  •   Premio Fundacion Araucaria, Grant de Investigación

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile, 2012

    The best clinical paper presented at the XLVIX National Congress of the Chilean Society of Cardiology and Cardiovascular Surgery Comparación de Fosfolipasa A2 asociada a Lipoproteina y Proteína C-reactiva ultrasensible como determinantes de Síndrome Metabólico en sujetos sin Enfermedad Coronaria: en la búsqueda del Mejor Predictor. M. Acevedo, P. Varleta, V. Kramer, T. Quiroga, C. Prieto, J. Parada, M. Adasme, L. Briones, C. Navarrete.

  •   Fundacion de Cardiologia

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile, 2012

    Premio Fundacion de Cardiologia de Chile, al mejor Trabajo de Investigación sobre Prevención de las Enfermedades The best clinical paper presented at the XLVIX National Congress of the Chilean Society of Cardiology and Cardiovascular Surgery. Niveles de fosfolipasa A2 asociada a lipoproteína en sujetos sin Enfermedad Coronaria con Riesgo Cardiovascular Variable: un nuevo biomarcador. M. Acevedo, P. Varleta, V. Kramer, T. Quiroga, C. Prieto, J. Parada, M. Adasme, L. Briones, C. Navarrete.

  •   Cardiovascular Prevention Award

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile, 2014

    "Superiority of the new ACC/AHA 2013 risk score, over the score of Traditional Framingham, in the mortality prediction in Santiago". LI Chilean Congress of Cardiology and Cardiovascular Surgery. 29 Nov-02 Dec 2014, Viña del Mar-Chile.

  •   Best abstract award

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile, 2014

    Best abstract award (highest ranking Chilean), accepted for Poster at ACC 2014, Washington, USA, March 29-31,2014.

  •   Award "Chilean Society of Cardiology and Cardiovascular Surgery, for the Best Work on Prevention

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile, 2016

    Award "Chilean Society of Cardiology and Cardiovascular Surgery, for the Best Work on Prevention "Waist and body mass index are the best anthropometric predictors in the reduction and progression of the aggregation of risk factors.

  •   Award for the best work sent from Chile to the ACC

    AMERICAN COLLEGE OF CARDIOLOGY, CONGRESS

    Estados Unidos, 2016

    Award for the best work sent from Chile to the ACC, Chicago- USA. 2-4 April 2016.

  •   Best Latin American Abstract Award.

    AMERICAN HEART ASSOCIATION

    Estados Unidos, 2018

    Best Latin American Abstract Award. American Heart Association 2018 - Cardiovascular Health in Women from Santiago: Randomized Intervention through cell phone text messaging.


 

Article (107)

Long-term maternal cardiovascular risk after preeclampsia: a latent vascular enemy
Mobile-phone text messaging to promote ideal cardiovascular health in women
Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women
Conciencia de Enfermedad Cardiovascular y Conocimiento sobre Factores de Riesgo y Prevención Cardiovascular: Resultados Chilenos de Encuesta SIAC Cono Sur
Gliflozins and Atrial Fibrillation
Anthropometric and blood pressure changes in patients with or without nutritional counselling during cardiac rehabilitation: a retrospective study
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Prevalence and determinants of ideal cardiovascular health in a latin women cohort: a cross-sectional study
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Cardiorespiratory fitness improves prediction of mortality of standard cardiovascular risk scores in a Latino population
Low Cardiovascular Disease Awareness in Chilean Women: Insights from the ESCI Project
Recomendaciones en la prevencion secundaria de Cardiopatía isquémica en la mujer
Urinary sodium-to-potassium ratio and body mass index in relation to high blood pressure in a national health survey in Chile
Conocimiento sobre enfermedad coronaria en familiares de pacientes con evento cardiovascular
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Ejercicio: una herramienta clave en la prevención cardiovascular. Consenso de la Sociedad Chilena de Cardiología y Cirugía Cardiovascular y de la Sociedad Chilena de Kinesiología en Cardiología y Cirugía Cardiovascular.
Five o'clock tea and the risk of metabolic syndrome
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Cardiovascular diagnostic tests: Gender differences in their interpretation? [Exámenes diagnósticos cardiovasculares: ¿diferencias de género en su interpretación?]
OBJETIVOS TERAPÉUTICOS EN HIPERTENSIÓN ARTERIAL:METAS DE PRESIÓN ARTERIAL EN LOS DIVERSOS SUBGRUPOS DE HIPERTENSOS
[Evaluation the American College of Cardiology and American Heart Association Predictive score for cardiovascular diseases]
Atherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment Expert's position paper made by The Latin American Academy for the Study of Lipids (ALALIP) Endorsed by the Inter-American Society of Cardiology (IASC), the South American Society of Cardiology (SSC), the Pan-American College of Endothelium (PACE), and the International Atherosclerosis Society (IAS)
Does Good Aerobic Capacity Attenuate the Effects of Aging on Cardiovascular Risk Factors? Results from a Cross-Sectional Study in a Latino Population
Does Good Aerobic Capacity Attenuate the Effects of Aging on Cardiovascular Risk Factors? Results from a Cross-Sectional Study in a Latino Population.
Evaluation the American College of Cardiology and American Heart Association Predictive score for cardiovascular diseases
Mobile phone text messaging improves antihypertensive drug adherence in the community
Mobile phone text messaging improves antihypertensive drug adherence in the community
Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin, but not by atorvastatin
Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin, but not by atorvastatin.
Waist to stature (height) ratio and clustering of metabolic syndrome components in Chilean children and adolescents.
Adherencia farmacológica y prevención secundaria cardiovascular: una de las principales barreras en el tratamiento de la enfermedad ateroesclerótica. Posición del Departamento de Prevención
Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry
Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE)
[Assessment of adherence to antihypertensive therapy].
Body fat and its relationship with clustering of cardiovascular risk factors
Comparison of Lipoprotein-Associated Phospholipase A2 and High Sensitive C-Reactive Protein as Determinants of Metabolic Syndrome in Subjects without Coronary Heart Disease: In Search of the Best Predictor
Impaired Fasting Glucose in Nondiabetic Range: Is It a Marker of Cardiovascular Risk Factor Clustering?
Patient Adherence to a Cardiovascular Rehabilitation Program: What Factors Are Involved?
Prevalencia y determinantes de adherencia a terapia antihipertensiva en pacientes de la Región Metropolitana
Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
Nuevas guías ACC / AHA 2013 en el manejo del colesterol:Una mirada crítica del Departamento de Prevención Cardiovascular de la Sociedad Chilena de Cardiología y Cirugía Cardiovascular
Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors
Carotid intima media thickness and C reactive protein among overweight or obese subjects without metabolic syndrome
Cholesterol Levels and the Association of Statins With In-Hospital Mortality of Myocardial Infarction Patients Insights From a Chilean Registry of Myocardial Infarction
¿Sirven los marcadores de riesgo no tradicionales en la diferenciación del riesgo cardiovascular en adultos jóvenes con exceso de peso?
Agregación de factores de riesgo cardiovascular y conciencia de enfermedad en trabajadores de un hospital universitario
Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation
Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation
Cardiovascular risk factors in a group of health care workers
Cardiovascular risk factors in a group of health care workers Agregación de factores de riesgo cardiovascular y conciencia de enfermedad en trabajadores de un hospital universitario
Relación colesterol total a HDL y colesterol no HDL: los mejores indicadores lipídicos de aumento de grosor de la íntima media carotidea
Cardiovascular risk factors among young subjects with high carotid intima media thickness
Common Carotid Artery Intima-Media Thickness: The Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) Study Results
Hipertensión arterial: el factor de riesgo más importante para grosor íntima-media carotídeo elevado y placa carotídea en adultos de Santiago
Perfil de riesgo cardiovascular en adultos jóvenes asintomáticos con grosor íntima media carotídeo elevado
Risk factors for a high carotid intima media thickness among healthy adults
Strain y Strain rate auricular izquierdo evaluado por speckle tracking está relacionado a PCR ultrasensible en adolescentes obesos
Adiponectin levels, cardiometabolic risk factors and markers of subclinical atherosclerosis in children
Association between a cardiovascular risk score and early markers of atherosclerotic disease in Chilean children
Association between a cardiovascular risk score and early markers of atherosclerotic disease in chilean children validación de un puntaje de riesgo cardiovascular en niños españoles aplicado a una población de escolares de santiago de chile
Dyslipidemia in seven Latin American cities: CARMELA study
La atorvastatina no modifica el incremento agudo de los niveles de p-selectina y fibrinógeno inducido con esfuerzo físico máximo
Long term follow up of patients consulting in a Chest Pain Unit
Long term follow up of patients consulting in a chest pain unit Seguimiento alejado de pacientes evaluados en una unidad de dolor torácico
Razón cintura estatura como predictor de riesgo cardiometabólico en niños y adolescentes
Role of the 207-218 peptide region of Moloney murine leukemia virus integrase in enzyme catalysis
Seguimiento alejado de pacientes evaluados en una Unidad de Dolor Torácico
Validación de un puntaje de riesgo cardiovascular en niños españoles aplicado a una población de escolares de Santiago de Chile
Waist height ratio, ultrasensitive c reactive protein and metabolic syndrome in children
Waist height ratio, ultrasensitive c reactive protein and metabolic syndrome in children Índice cintura estatura y agregación de componentes cardiometabólicos en niños y adolescentes de Santiago
Índice cintura estatura y agregación de componentes cardiometabólicos en niños y adolescentes de Santiago
Actividad física y potencia aeróbica: ¿Cómo influyen sobre los factores de riesgo cardiovascular clásicos y emergentes?
Association between cardiorespiratory fitness and cardiovascular risk factors in healthy individuals
Association between cardiorespiratory fitness and cardiovascular risk factors in healthy individuals Actividad física y potencia aeróbica: ¿Cómo influyen sobre los factores de riesgo cardiovascular clásicos y emergentes?
Blood pressure and family history of hypertension in children from Santiago, Chile
Early markers for atherosclerosis and metabolic syndrome in children
Early markers for atherosclerosis and metabolic syndrome in children Marcadores de aterosclerosis temprana y síndrome metabólico en niños
Marcadores de aterosclerosis temprana y síndrome metabólico en niños
Modificación del grosor intima-media carotídeo según factores de riesgo clásicos y síndrome metabólico con o sin inflamación
Perfil de presión arterial e historia familiar de hipertensión en niños escolares sanos de Santiago de Chile
Cardiovascular risk factors for heart disease and stroke in women by age and time since menopause, in seven Latin American cities: The CARMELA study
High sensitivity C-reactive protein and endothelial function in Chilean patients with history of Kawasaki disease
Arterioesclerosis subclínica, factores de riesgo cardiovascular clásicos y emergentes en niños obesos chilenos
Chest pain unit: first experience in Chile
Chest pain unit: First experience in Chile Unidad de dolor torácico: Primera experiencia en Chile
Relationship of C-reactive protein to adiposity, cardiovascular risk factors and subclinical atherosclerosis in healthy children Proteína C reactiva y su relación con adiposidad, factores de riesgo cardiovascular y aterosclerosis subclínica en niños sanos
Unidad de dolor torácico: primera experiencia en Chile
Use of endovascular stents in atherosclerotic renovascular stenosis: blood pressure and renal function changes in hypertensive patients.
C-reactive protein and atrial fibrillation: Evidence for the presence of inflammation in the perpetuation of the arrhythmia"
Biomarcadores coronarios y evolución clínica alejada en pacientes con síndromes coronarios agudos sin elevación del segmento ST
Coronary biomarkers and long-term clinical outcome in acute coronary syndrome without ST segment elevation
Insuficiente control de factores de riesgo en prevención secundaria cardiovascular
Prevalence of cardiovascular risk factors among patients suffering vascular events on admission and one year later
Administration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function, exercise capacity, and neurohormonal status
Effects of glucose-insulin-potassium solution on myocardial salvage and left ventricular function after primary angioplasty
PREDICTORES ECOCARDIOGRAFICOS DE RITMO SINUSAL A 30 DIAS Y 1 AÑO EN PACIENTES CON FIBRILACION AURICULAR NO VALVULAR
PROTEINA C REACTIVA Y FIBRILACION AURICULAR: EVIDENCIA DE UN PROCESO INFLAMATORIO EN LA INICIACION Y PERPETUACION DE LA ARRITMIA
Hipercoagulabilidad en fibrilación auricular y su relación con factores de riesgo para embolia sistémica
Hypercoagulability in atrial fibrillation and its relationship with risk factors for systemic embolism Hipercoagulabilidad en fibrilación auricular y su relación con factores de riesgo para embolia sistémica.
Association of noninvasive markers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty
Elevated fibrinogen and homocysteine levels enhance the risk of mortality in patients from a high-risk preventive cardiology clinic.
SOLUCION GIK EN EL INFARTO AGUDO AL MIOCARDIO. EL RESURGIMIENTO DE UNA ANTIGUA TERAPIA
Enalapril restores depressed circulating insulin-like growth factor 1 in patients with chronic heart failure
Selective increase in cardiac IGF-1 in a rat model of ventricular hypertrophy

Abstract (24)

No contribution of ankle brachial index as a risk reclassification tool for statin prescription according to the new ACC/AHA cholesterol guideline
Lipoprotein associated phospholipase A2 and C-reactive protein as predictors of metabolic syndrome in subjects without cardiovascular disease
DOES THE INTIMA MEDIA THICKNESS PREDICT MORTALITY BEYOND TRADITIONAL RISK FACTORS?: SEVEN YEAR FOLLOW UP OF CARMELA-CHILE STUDY
NON TRADITIONAL RISK FACTORS AND MORTALITY: DO THEY ADD INFORMATION BEYOND TRADITIONAL RISK FACTORS?
Statins do not correct hypofibrinolysis in hypercholesterolemia. correcting LDL-cholest unveils an inverse relation of HDL-cholest and clot lysis time
EVALUATION OF CLOT LYSIS TIME WITH PLATELETS: CORRELATION WITH CARDIOVASCULAR RISK MARKERS
Clot lysis time (CLT) of PRP and PPP in hypercholesterolemia. Effect of atorvastatin and relationships with inflammatory markers
Platelet Tissue Factor Activity In Patients with Hypercholesterolemia: Modulation of Procoagulant Activity by Statins
Changes in Carotid Intima-Media Thickness According to the Presence of the Metabolic Syndrome With and Without Chronic Inflammation
Achievement of treatment targets of cardiovascular risk factors in a pilot secondary prevention program in Chile
Awareness, treatment and control of the combination of hypertension and hypercholesterolemia in a primary prevention population in chile
Six minute walking test in cardiac rehabilitation: factors related to performance
Abdominal obesity, body mass index and physical activity: How do they modify the Framingham risk score?
C-reactive protein, traditional risk factors and anthropometric features in Chilean children
Abdominal obesity and physical activity: do they add something to the Framingham risk score?
Cardiorrespiratory fitness, metabolic syndrome and subclinical inflammation in a primary prevention cardiology unit
Hypertension and hypercholesterolemia: Achievement of treatment targets in a primary prevention population
Characteristics of heart failure in women: Findings in Chilean National Registry of Heart Failure
Lack of association of C-reactive protein with subclinical atherosclerosis evaluated by carotid intima-media thickness in a healthy Chilean urban population. A CARMELA substudy
C-reactive protein and soluble thrombomodulin: biochemical markers of maintenance of sinus rhythm at 1-year follow-up in patients with non-valvular atrial fibrillation
C-reactive protein in atrial fibrillation: Evidence for the presence of inflammation in the genesis and perpetuation of the arrhythmia
Clinical value of echocardlographic markers for the prediction of sinus rhythm maintenance at 30-day and 1-year follow-up in patients with non-valvular atrial fibrillation
C-reactive protein and atrial fibrillation: evidence of an inflammatory process in the initiation and perpetuation of the arrhythmia
Thrombin-antithrombin levels are directly associated with heart rate at entry in patients with non-valvular atrial fibrillation

Errata (1)

Hypertension in women (vol 141, pg 237, 2013)

Review (6)

Exercise and cardiac rehabilitation in secondary cardiovascular prevention
Hipertensión arterial en la mujer adulta
Hypertension in women
Microalbuminuria y excreción urinaria de albúmina en la práctica clínica
Hypertension in adolescents
Las preguntas que el clínico debe hacerse en un paciente hipertenso al sospechar una Hipertensión Secundaria
145
MONICA ACEVEDO

Titular Professor

Division of Cardiovascular Diseases

P. UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

50
Ramon Corbalan

Director

Division of Cardiovascular Diseases

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

13
Giovanna Valentino

Profesor Docente Asistente

Ciencias de la Salud

Pontificia Universidad Catolica de Chile

Santiago, Chile

12
Salesa Barja

Médico Nutrióloga pediátrica

Gastroenterología y Nutrición Pediátrica

Pontificia Universidad Católica de Chile

Santiago, Chile

9
Jaime Pereira

Jefe

Hematología-Oncología

ESCUELA DE MEDICINA, PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

8
JORGE JALIL

FULL PROFESSOR

ENFS CARDIOVASCULARES

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE, ESCUELA DE MEDICINA

Santiago, Chile

6
Olga Panes

Technical Director/ Associated Research

Hematology-Oncology

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

4
Pablo Castro

JEFE DIVISION

DIVISION ENFERMEDADES CARDIOVASCULARES

Pontificia Universidad Católica de Chile

SANTIAGO, Chile

3
Luigi Gabrielli

Profesor Asistente

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Chile

3
Diego Mezzano

Director

Hematology-Oncology

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

3
Valeria Matus

Associate Researcher

Hematology-Oncology

P. UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

3
Carolina Nazzal

Profesor Asociado

Instituto de Salud Poblacional

Universidad de Chile

Santiago, Chile

2
Attilio Rigotti

Full Professor

Nutrition, Diabetes and Metabolism

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE - ESCUELA DE MEDICINA - DEPTO DE GASTROENTEROLOGÍA

Santiago, Chile

2
Arnaldo Marín

Profesor Adjunto

Basico Clinico de Oncologia

Universidad de Chile

Santiago, Chile

2
Fernando Lanas

Profesor titular

Medicina Interna

UNIVERSIDAD DE LA FRONTERA

Temuco, Chile

2
CLAUDIA BAMBS

PROFESORA ASOCIADA

SALUD PÚBLICA

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

2
Oscar León

FACULTAD DE MEDICINA ICBM PROG VIROLOGIA

Santiago, Chile

2
Samuel Cordova

ESCUELA DE MEDICINA, PONTIFICA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Oslando Padilla

Estadístico

Salud Pública

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Roberto Ebensperger

Associate Professor

Pharmacy

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Gabriel Cavada

Académico, Jefe de Programa

Instituto de Salud Poblacional

Universidad de Chile

Santiago, Chile

1
Rodrigo Hoyos

Profesor Asistente

Enfermedades Infecciosas e Inmunología Pediátrica

Escuela de Medicina, Pontificia Universidad Católica de Chile

Santiago, Chile

1
SERGIO LAVANDERO

Director

Advanced Center for Chronic Diseases (ACCDiS)

UNIVERSIDAD DE CHILE, FAC CIENCIAS QUÍMICAS Y FARMACÉUTICAS

Santiago, Chile

1
Eduardo Aranda

Biochemist

Hematology

P. UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

1
Attilio Rigotti

Full Professor

Nutrition, Diabetes and Metabolism

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Dante Lindefjeld

Staff, Assistant Professor

Cardiology

Clinical Hospital of the Pontificia Universidad Católica de Chile

Santiago, Chile

1
Octavio Monasterio

Profesor Titular

Departamento de Biología

UNIVERSIDAD DE CHILE, FACULTAD DE CIENCIAS, DEPARTAMENTO DE BIOLOGÍA

Santiago, Chile

1
Paola Viviani

Profesor Asistente, categoría Ordinaria

Salud Pública

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

1
Rodrigo Alonso

Director Jefe Departamento

Nutrición Clínica

Clínica Las Condes

Santiago, Chile

1
Gonzalo Martínez

Director

División de Enfermedades Cardiovasculares

Hospital Clínico Universidad Católica

Santiago, Chile

1
Jonathan Kraus

ENDOCRINÓLOGO PEDIATRA

PEDIATRÍA

HOSPITAL LUIS CALVO MACKENNA

SANTIAGO, Chile

1
Daniel Morales

Jefe Unidad Paciente Critico

Unidad de Paciente Critico (UPC)

Hospital La Florida

Santiago, Chile

1
Arturo Borzutzky

Chief; Associate Professor

Department of Pediatric Infectious Diseases and Immunology

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Monica Acevedo

Profesor Asistente

Instituto de Ciencias Biomédicas

UNIVERSIDAD DE CHILE

Santiago, Chile

1
samuel duran

Docente investigador

Universidad San Sebastian

Santiago , Chile

1
Susana Contreras

Assistant Professor

Nutrition and Dietetics

Universidad San Sebastián

Santiago, Chile